ALX Oncology Holdings Inc. (ALXO) has a consensus analyst rating of Buy, based on 7 analysts covering the stock. Of those, 6 recommend buying, 1 recommend holding, and 0 recommend selling.
The analyst consensus price target for ALXO is $4.00, representing a +147.7% upside from the current price of $1.615. Price targets range from a low of $4.00 to a high of $4.00.
